NKTR
Nektar Therapeutics
42.20$
-3.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +135.5% | +34.1% | +89.8% | +24.8% | +50.0% | +22.4% | +12.0% | +7.5% | +10.5% | +72.4% | +25.4% | -67.0% | -20.2% | +121.1% | -55.1% | +13.6% | +83.4% | +34.8% | +15.0% | -28.3% | +86.0% | +287.8% | -90.4% | +33.4% | -33.4% | -9.7% | -2.1% | +9.2% | -43.9% | |
| – | – | – | – | – | -96.1% | +68.4% | +109.1% | +34.9% | +81.8% | +228.1% | +24.9% | -76.2% | -11.7% | -17.1% | -14.7% | +39.0% | +26.6% | -25.9% | +19.5% | -11.4% | +1.1% | -20.1% | -12.4% | -8.9% | +27.8% | -13.1% | +69.4% | -16.3% | -100.0% | |
| – | +100.6% | +34.1% | +89.8% | +24.8% | +42.0% | +19.8% | +4.3% | +3.2% | -4.4% | +10.4% | +26.0% | -56.1% | -25.7% | +225.4% | -62.8% | +2.4% | +117.5% | +55.9% | +14.2% | -31.2% | +105.0% | +321.7% | -92.0% | +43.1% | -42.3% | -8.6% | -24.1% | +26.7% | -18.5% | |
| – | +64.2% | +49.7% | +81.0% | +58.5% | +37.5% | +12.7% | -16.4% | +1.5% | +13.6% | -1.5% | +2.8% | +0.5% | -38.4% | +13.6% | +17.3% | +17.3% | +27.8% | -22.2% | +23.7% | +11.5% | +31.7% | +48.8% | +8.8% | -6.0% | -2.1% | -45.5% | -47.7% | +5.9% | -3.0% | |
| – | +58.2% | +32.5% | -6.2% | +77.0% | +35.4% | +37.9% | -15.4% | +40.7% | +41.6% | +78.6% | -28.1% | -8.6% | -20.4% | 0.0% | +14.1% | -11.0% | -2.6% | +1.0% | +5.7% | +2.3% | +18.3% | +55.5% | +21.2% | +6.0% | +17.3% | -24.8% | -16.2% | -0.9% | -10.5% | |
| – | +52.9% | +46.1% | +64.3% | +60.5% | +59.3% | +2.1% | -16.0% | +6.8% | +57.4% | -2.3% | -37.5% | -14.8% | -1.2% | +9.5% | +16.4% | +9.7% | +21.2% | -18.2% | +19.8% | +9.7% | +29.3% | +49.9% | +10.9% | -3.7% | +1.9% | -40.6% | -38.5% | -9.4% | +7.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -164.0% | – | – | – | – | – | – | |
| – | – | – | – | – | +10.7% | +23.7% | +7.7% | +43.9% | -45.3% | +43.8% | -8.0% | -18.5% | -19.9% | -8.2% | -8.5% | +228.1% | +21.5% | -4.9% | +0.4% | +8.4% | -2.9% | +4.5% | +8.4% | -19.9% | +27.5% | -38.9% | -12.4% | +11.0% | -6.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -392.4% | – | – | – | – | – | – | – | – | – | -164.5% | – | – | – | – | – | – | |
| – | – | – | – | +327.2% | +315.1% | -94.7% | -97.7% | -196.4% | – | – | +58.1% | -161.6% | – | – | +15.6% | -60.1% | +453.0% | -122.8% | – | +73.1% | -29.7% | +129.2% | -56.6% | -19.6% | +13.0% | +477.2% | -106.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -164.7% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -3,082.1% | – | – | – | – | – | – | – | – | – | -152.1% | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.